Methylphenidate and brain response to alcohol cues in young adults
Part of Mental health clinical trials.
This study tests whether a medication called methylphenidate (commonly used for ADHD) changes how your brain responds to alcohol-related cues seen in an MRI scanner. It may help understand how to reduce cravings in young adults with alcohol use disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 25 years old.
- You need to have alcohol use disorder or a high score on a standard alcohol screening test (AUDIT of 8 or more).
- You must speak English fluently and have normal or corrected vision (glasses or contacts are fine).
- You cannot have any other substance use disorder (except occasional marijuana or nicotine) or serious mental health conditions like psychosis.
- You must be able to take methylphenidate and safely undergo an MRI (no metal implants, no high blood pressure, no seizures, no liver disease).
- If you are female, you cannot be pregnant or trying to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called disulfiram (Antabuse) can help people with alcohol use disorder (AUD) feel less anxious when they stop drinking. Researchers will also use brain scans (MRI) to look at how the brain changes during early abstinence.
This study is looking at ways to increase “alcohol abstinence,” meaning drinking less or stopping. It focuses on young adults who currently drink and have symptoms of alcohol use disorder, and it may help them build skills to reduce or stop drinking.
This study tests whether brexpiprazole can help adults with alcohol use disorder. You must currently not be taking alcohol-focused treatment or alcohol medicines, and you’ll likely complete questionnaires and brain scans.
This study looks at whether alcohol use disorder affects the cerebellum, a part of the brain involved in movement and balance. It may help researchers understand brain impacts and guide better treatments.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This study gives a controlled amount of alcohol and uses brain MRI scans to understand how alcohol affects people with bipolar disorder. It may help researchers find brain and behavior patterns that explain differences in alcohol responses.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.